Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Torrent Pharmaceuticals Limited
TORNTPHARM | NSE
4,117.20
INR-30.00
-0.72%
TORNTPHARM | NSE
Loading StockChartView...
About Torrent Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
4,117.20
Open
4,151.00
High
4,158.00
Low
4,097.40
Torrent Pharmaceuticals Limited engages in the research development manufacturing and marketing of generic pharmaceutical formulations in India the United States Germany Brazil and internationally. It offers products in various therapeutic areas including cardiovascular central nervous system gastrointestinal women healthcare diabetology pain management gynecology oncology and anti-infective as well as provides vitamins minerals and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib Molnupiravir and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
View LessTORNTPHARM | NSE
Risk
21.0
Sharpe
1.18
Luna's Score
63/100
Recommendation
Hold
Luna says (TORNTPHARM | NSE)
What's Working
Low 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
16.2%1 month
21.0%3 months
21.4%6 months
21.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
66.22
Fwd. PE
56.50
Price to book
16.77
Debt to equity
0.59
Debt to assets
0.27
Ent. to EBITDA
32.74
Ent. to rev.
10.89
PEG
-
Other Fundamentals
EBITDA
34.74B
MarketCap
1,393.45B
MarketCap(USD)
14.56B
Div. yield
0.82
Op. margin
25.43
Erngs. growth
20.80
Rev. growth
10.30
Ret. on equity
25.38
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
169.90
Range1M
463.90
Range3M
787.90
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.65
Price X volume
1.16B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 32.74 | 24.85 | Expensive |
| Ent. to Revenue | 10.89 | 11.40 | Par |
| PE Ratio | 66.22 | 51.36 | Expensive |
| Price to Book | 16.77 | 6.83 | Expensive |
| Dividend Yield | 0.82 | 0.52 | Leader |
| Std. Deviation (3M) | 21.44 | 42.17 | Lower Risk |
| Debt to Equity | 0.59 | 0.35 | Expensive |
| Debt to Assets | 0.27 | 0.17 | Expensive |
| Market Cap | 1,393.45B | 290.82B | Market Leader |
